Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Post by general360on Oct 18, 2022 12:20pm
1055 Views
Post# 35031658

Long COVID

Long COVID
Addiction drug shows promise lifting long COVID brain fog, fatigue


https://www.yahoo.com/news/addiction-drug-shows-promise-lifting-101204918.html


let's wait another YEAR before we start our on the down-low P3 COVID trial.  it's not even a COVID trial apparently any longer; it's a LONG COVID trial, which is quite different.

what a fcuking waste of space RVX management is; driven my investment into the ground with false promises, empty forward looking statements that NEVER come true and in fact look like outright outrageous LIES.

if the insiders are only HALF as mad as i am there would have already been CHANGE AT THE TOP.

the Board of Directors needs to be SACKED.  FIRED.  EVERY LAST ONE OF 'EM.
the CEO is the chair of the board so it's one ole boys club.

whats it going to take to right the ship?  an outright fire sale?

too bad we cant get an activist investor to ACTIVATE!
<< Previous
Bullboard Posts
Next >>